AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong
· Delayed Price · Currency is HKD 2.380
-0.120 (-4.80%)
Apr 29, 2026, 4:08 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 3.07 billion as of April 29, 2026. Its market cap has decreased by -37.50% in one year.
Market Cap
3.07B
Enterprise Value
4.82B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.38
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 3.07B, a decrease of -84.78%. That is a compound annual growth rate of -41.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.92B | -25.86% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 3.13B |
| Medtide | 3.00B |
| Antengene Corporation | 3.44B |
| BioDlink International Company | 3.54B |
| Viva Biotech Holdings | 3.61B |
| Mirxes Holding Company | 3.66B |
| Clover Biopharmaceuticals | 3.71B |
| TYK Medicines | 3.89B |